Pharmaceutical firm Schering reported preliminary 2001 sales of $4.3 billion, up 10% over 2000 sales after adjusting for currency effects. The Berlin-based vendor had preliminary net income of $372 million, up 24% compared with 2000. Schering will publish its annual report on March 1.
By AuntMinnie.com staff writersFebruary 5, 2002
Related Reading
Schering buys rest of CIS bio, January 3, 2002
Schering gets approval for Resovist in Sweden, March 28, 2001
Schering gains Japanese rights to Epix’s MS-325, January 9, 2001
Copyright © 2002 AuntMinnie.com